Clinical Trial Update: ctDNA for Risk Stratification in Melanoma

View source ↗

Summary

This clinical trial update describes evaluating circulating tumor DNA (ctDNA) for risk stratification in melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Melanoma (Skin Cancer) | Status: ACTIVE_NOT_RECRUITING